Exabis Library
Welcome to the e-CCO Library!
P0324: Lower Bone Mineral Density and alterations in bone biomarkers DKK-1x7x7x7 Sclerostinx7x7x7 and Periostin in individuals with Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0325: Is the augmentation index a good marker of cardiovascular risk in Crohn's disease?
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0326: Environmental factorsx7x7x7 genetic predisposition and subclinical inflammation in the development of perinuclear-antineutrophil cytoplasmic antibody (P-ANCA)-positive ulcerative colitis: A European twin study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0327: Histologic remission predicts endoscopic remission in patients with ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0328: Faecal calprotectin and MRI are complementary tools for assessing treatment efficacy and predicting the risk of bowel damage progression in Crohn's disease: results of the IZNOGOUD study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0329: Clostridium difficile infection associates with the need for biologics: a retrospective long-term analysis in a cohort of 102 ibd patients.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P032: Distinct immune cell trigger responses in Ulcerative Colitis – Results from an in vivo human intestinal injury model
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P032: Hepatocyte growth factor and MET in ulcerative colitis, novel drug targets impairing neutrophil recruitment?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P032: Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P032: IFN-γ controls the immunomodulatory properties of bone marrow mesenchymal stem cells via a microRNA29a/STAT-3 dependent mechanism
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P032: MiR-511 deficiency aggravates T cell transfer colitis in mice
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P032: The pharmacological profile of TOP1288, a narrow spectrum kinase inhibitor in clinical development as an anti-inflammatory treatment for ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0330: The diagnostic pathway of paediatric Inflammatory Bowel Disease in a Scottish regional centre beforex7x7x7 during and after the Covid Pandemic: Good access to endoscopy but MRI lagging behind
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0331: Insights from the Polish Registry of Microscopic Colitis. The Overlapping Symptoms of Microscopic Colitis and Irritable Bowel Syndrome.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0332: Optimization and assessment of colonoscopy preparation in Inflammatory Bowel Disease: a comprehensive single-center analysis with focus on disease-specific factors
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0333: Predictive factors for thiopurine treatment failure in anti-TNF naïve IBD patients: Insights from a tertiary care Hepato-Gastroenterology center experience
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0334: AGMB-129x7x7x7 an investigational ALK5 inhibitor for the treatment of Fibrostenosing Crohn’s Disease (FSCD)x7x7x7 shows gastrointestinal (GI) restricted pharmacokinetics (PK) and a favorable safety profile in healthy subjects
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0335: Development of an entrustable professional activity for intestinal ultrasound in North America
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0336: From inflammation to depression: key biomarkers for Inflammatory Bowel Disease-related Major Depressive Disorder
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM